Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia

NCT00587171 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2016-07-13

Study results available
· View outcomes & findings →

Summary

This study is comparing the effectiveness of patching combined with active vision therapy plus near activities versus patching combined with control vision therapy plus near activities for moderate amblyopia (20/40-20/100) in 7 to \<13 year olds.

The primary outcome measure is the proportion of patients with visual acuity of 20/25 or better in the amblyopic eye at the 17-week masked exam. These patients will be considered treatment responders. The primary analysis will consist of a comparison between the 2 treatment groups of the proportion of treatment responders with adjustment for baseline visual acuity.

Secondary outcomes are stereoacuity at the 17-week masked exam, mean improvement in visual acuity at the 17-week masked exam, and rate of improvement of visual acuity.

Conditions

  • Amblyopia

Interventions

DEVICE

Patching

2 hours daily patching

PROCEDURE

Near activities

30 minutes daily near activities at home

PROCEDURE

Active vision therapy

30 minutes of daily at-home active vision therapy and a weekly 45 minute in-office active vision therapy session

PROCEDURE

Control vision therapy

30 minutes of daily at-home control vision therapy and a weekly 45 minute in-office control vision therapy session

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH
  • Jaeb Center for Health Research

    lead OTHER

Principal Investigators

  • Don W. Lyon, O.D. · Indiana University

  • David T. Wheeler, M.D. · Casey Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-03-31
Completion
2009-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00587171 on ClinicalTrials.gov